Triglyceride-glucose index and triglyceride-glucose–body mass index as prognostic factors for early stage breast cancer patients receiving neoadjuvant chemotherapy

Triglyceride-glucose index and triglyceride-glucose–body mass index as prognostic factors for early stage breast cancer patients receiving neoadjuvant chemotherapy

Background: Insulin resistance (IR) is closely associated with the risk of breast cancer. The triglyceride-glucose (TyG) index and the triglyceride-glucose–body mass index (TyG-BMI) are considered surrogate indicators of IR; however, their prognostic value in breast cancer patients has not been disc...

Full description

Saved in:
Bibliographic Details
Main Authors: Fucheng Li, Tian Gao, Zhaoting Li, He Dou, Yuling Ba, Siyuan Jia, Danli Luo, Min Xiao
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Translational Oncology
Subjects:
TyG index
Breast cancer
Prognostic factor
TyG-BMI
Insulin resistance
Neoadjuvant chemotherapy
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523325000233
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S1936523325000233

Similar Items